ALFA News
Straight from the exchange filing
Every announcement Kwality Pharmaceuticals has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Kwality Pharmaceuticals announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Kwality Pharmaceuticals revises FY27 revenue target to ₹700Cr+ and eyes ₹1,500Cr by FY30. Highlights include biosimilar expansion and 26-27% EBITDA margins.
Kwality Pharmaceuticals reports 45.7% YoY revenue growth in Q1FY27 to ₹162.4 Cr. Management raises FY27 revenue guidance to ₹700+ Cr on strong export demand.
